This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
These key takeaways from the research letter on IVL-facilitated valvuloplasty for severely calcified mitral valve stenosis are published in the Journal of the American College of Cardiology (JACC) CardiovascularInterventions. an interventional cardiologist and structural heart disease expert at Henry Ford Health.
Circulation: CardiovascularInterventions, Ahead of Print. Some patients with aortic stenosis may require multiple valveinterventions in their lifetime, and choosing transcatheter aortic valve replacement (TAVR) as the initial intervention may be appealing to many.
Circulation: CardiovascularInterventions, Ahead of Print. BACKGROUND:Transcatheter heartvalve (THV) underexpansion after transcatheter aortic valve replacement may be associated with worse outcomes.
Transcatheter mitral valve-in-ring (MViR) using third-generation balloon-expandable aortic transcatheter heartvalves was associated with a significant reduction in mitral regurgitation (MR) and improvement in heart failure symptoms at one year, with the tradeoff of elevated valvular gradients and a high rate of reintervention, according to a recent (..)
The fifth-generation SAPIEN 3 Ultra Resilia valve (S3UR) transcatheter heartvalve (THV), used in TAVR procedures, is associated with lower mean gradients and lower rates of paravalvular leak (PVL) when compared to outcomes from the SAPIEN 3 (S3) and SAPIEN 3 Ultra (S3U) valves, according to a study presented at CRT 2024 and simultaneously published (..)
The existing treatment pathway for transcatheter aortic valve implantation (TAVI) traditionally relies on tertiary HeartValve Centre workup. However, this has been associated with delays to treatment, in breach of British CardiovascularIntervention Society targets. ±64 to 126±257 days, p<0.00001).
Circulation: CardiovascularInterventions, Volume 16, Issue 11 , Page e012966, November 1, 2023. Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients.
Circulation: CardiovascularInterventions, Ahead of Print. BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Self-expanding transcatheter heartvalves were used in the majority of patients (n=1160; 91.4%). Poverall=0.765; 1 year: 1.4%
Under the expert guidance of our seasoned instructors and anatomy specialist, this session offered a wealth of practical insights, allowing attendees to delve into the intricacies of heartvalve anatomy. Behind every success story, there are dedicated mentors and instructors. We extend our deepest gratitude to Assoc.
Under the expert guidance of our seasoned instructors and anatomy specialist, this session offered a wealth of practical insights, allowing attendees to delve into the intricacies of heartvalve anatomy. Behind every success story, there are dedicated mentors and instructors. We extend our deepest gratitude to Assoc.
His research centers on the comprehensive management of patients post-TAVR, transcatheter mitral and tricuspid valveinterventions, and advanced imaging techniques in structural heart disease.
EuroPCR 2024 Date: May 14-17, 2024 Location: Paris, France, and online Overview: EuroPCR is dedicated to sharing knowledge, experience, and practice in cardiovascularinterventional medicine. The course is relevant for the entire heartvalve team. Registration: Visit PCR London Valves website for registration options.
His research centers on the comprehensive management of patients post-TAVR, transcatheter mitral and tricuspid valveinterventions, and advanced imaging techniques in structural heart disease.
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content